Cannabinoid Receptor
The cannabinoid receptor (CB1 and CB2) is a member of G-protein coupled receptor which plays a significant role in physiologic processes such as cognitive and immune functions.
Products for Cannabinoid Receptor
- Cat.No. Product Name Information
-
GC15327
Tetrahydromagnolol
Magnolignan
peripheral CB2 receptor agonist
-
GC39666
TM38837
TM38837 is a peripheral selective cannabinoid receptor type 1 (CB1) receptor antagonist.
-
GC12978
Tocrifluor T1117
T1117
Tocrifluor T1117 (T1117), a fluorescent form of the cannabinoid CB1 receptor antagonist AM251, is a selective fluorescent GPR55 ligand.
-
GC37889
VCE-004.8
VCE-?004.8
VCE-004.8 (VCE-004.8) is an orally active, specific PPARγ and CB2 receptor dual agonist.
-
GC70118
Vicasinabin
RG7774
Vicasinabin (RG7774) is an effective agonist of the cannabinoid receptor 2 (CB2). Vicasinabin has potential for researching human diseases, including chronic pain, atherosclerosis, bone regulation, neuroinflammation and other related conditions (information extracted from patent US20130116236A1).
-
GC45150
Voacamine
NSC 82591
Voacamine is an alkaloid originally isolated from Voacanga that has diverse biological activities.
-
GC37935
WIN 55,212-2 Mesylate
WIN 55,212-2 Mesylate is a potent aminoalkylindole cannabinoid (CB) receptor agonist with Ki values of 62.3nM and 3.3nM for human recombinant CB1 and CB2 receptors, respectively.
-
GC31809
Yangonin
An Analytical Reference Standard
-
GC33681
β-Caryophyllene
BCP, (-)-β-Caryophyllene, (-)-trans-Caryophyllene, NSC 11906
β-Caryophyllene is a CB2 receptor agonist.